US WorldMeds
US WorldMeds to Present Final SPEARHEAD-1 Results for TECELRA® in Late-Breaking Oral Presentation at CTOS 2026
Results from all cohorts of the registrational trial selected for the session "Late Breaking Abstracts and Updates – Can They Change Practice?"…